Farmacología y Toxicología
Fachbereich
Vall d'Hebron Institut de Recerca
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Vall d'Hebron Institut de Recerca (3)
2022
2021
-
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
The Lancet, Vol. 398, Núm. 10295, pp. 121-130
2008
-
Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice
Journal of Neurochemistry, Vol. 107, Núm. 4, pp. 1102-1112